Prime Medicine, Inc. (PRME)
3.61
-0.38
(-9.52%)
USD |
NASDAQ |
Oct 12, 16:00
3.66
+0.05
(+1.39%)
After-Hours: 07:24
Prime Medicine Total Return Level : 3.61 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 3.61 |
| October 09, 2026 | 3.99 |
| October 08, 2026 | 3.58 |
| October 07, 2026 | 3.90 |
| October 06, 2026 | 3.50 |
| October 05, 2026 | 3.21 |
| October 02, 2026 | 2.98 |
| October 01, 2026 | 2.99 |
| September 30, 2026 | 3.055 |
| September 29, 2026 | 3.09 |
| September 28, 2026 | 2.875 |
| September 25, 2026 | 2.90 |
| September 24, 2026 | 3.07 |
| September 23, 2026 | 3.13 |
| September 22, 2026 | 3.54 |
| September 21, 2026 | 3.19 |
| September 18, 2026 | 3.12 |
| September 17, 2026 | 3.14 |
| September 16, 2026 | 3.00 |
| September 15, 2026 | 3.14 |
| September 14, 2026 | 3.18 |
| September 11, 2026 | 3.13 |
| September 10, 2026 | 3.35 |
| September 09, 2026 | 3.47 |
| September 08, 2026 | 3.56 |
| Date | Value |
|---|---|
| September 04, 2026 | 3.70 |
| September 03, 2026 | 3.71 |
| September 02, 2026 | 3.67 |
| September 01, 2026 | 3.57 |
| August 31, 2026 | 3.59 |
| August 28, 2026 | 3.61 |
| August 27, 2026 | 3.64 |
| August 26, 2026 | 3.58 |
| August 25, 2026 | 3.71 |
| August 24, 2026 | 3.25 |
| August 21, 2026 | 3.39 |
| August 20, 2026 | 3.24 |
| August 19, 2026 | 3.54 |
| August 18, 2026 | 3.05 |
| August 17, 2026 | 3.17 |
| August 14, 2026 | 3.09 |
| August 13, 2026 | 3.17 |
| August 12, 2026 | 3.20 |
| August 11, 2026 | 3.26 |
| August 10, 2026 | 3.15 |
| August 07, 2026 | 3.08 |
| August 06, 2026 | 2.95 |
| August 05, 2026 | 3.08 |
| August 04, 2026 | 2.98 |
| August 03, 2026 | 2.81 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Beam Therapeutics, Inc. | 25.13 |
| Twist Bioscience Corp. | 151.86 |
| Intellia Therapeutics, Inc. | 12.58 |
| Moderna, Inc. | 213.74 |
| Q32 Bio, Inc. | 8.74 |